China National Pharmaceutical Group Corporation
GPTKB entity
Statements (62)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:Company
|
| gptkbp:acquisition |
gptkb:China_National_Pharmaceutical_Group_Co.,_Ltd.
gptkb:Sinopharm_Group |
| gptkbp:collaborates_with |
research institutions
|
| gptkbp:contributedTo |
China's_economy
|
| gptkbp:employs |
over 100,000 people
|
| gptkbp:founded |
1998
|
| gptkbp:has_a |
patient safety
over 100 countries |
| gptkbp:has_a_focus_on |
research and development
public health chronic disease management patient-centered care digital health solutions pharmaceutical education. |
| gptkbp:has_a_role_in |
global health initiatives
|
| gptkbp:has_partnerships_with |
government health agencies
international pharmaceutical companies |
| gptkbp:hasPrograms |
international expansion
|
| gptkbp:headquarteredIn |
gptkb:Beijing
|
| gptkbp:headquarters |
gptkb:Beijing,_China
|
| gptkbp:heldIn |
global supply chains
|
| https://www.w3.org/2000/01/rdf-schema#label |
China National Pharmaceutical Group Corporation
|
| gptkbp:investmentFocus |
healthcare_infrastructure
|
| gptkbp:is_a_key_player_in |
China's_healthcare_system
|
| gptkbp:is_a_member_of |
gptkb:China_Pharmaceutical_Industry_Association
international pharmaceutical organizations |
| gptkbp:is_committed_to |
sustainable practices
research funding environmental sustainability community health programs |
| gptkbp:is_displayed_on |
gptkb:Hong_Kong_Stock_Exchange
|
| gptkbp:is_involved_in |
biotechnology
clinical trials medical research pharmaceutical logistics vaccine development healthcare education distribution of drugs healthcare_policy_advocacy healthcare_technology_innovation |
| gptkbp:is_known_for |
generic drugs
affordable medications innovative therapies COVID-19 vaccines clinical excellence |
| gptkbp:is_recognized_for |
quality control
supply chain efficiency ethical practices |
| gptkbp:leadership |
pharmaceutical distribution
|
| gptkbp:market |
significant_percentage_in_China
|
| gptkbp:operates_in |
medical devices
pharmaceutical industry |
| gptkbp:produces |
vaccines
|
| gptkbp:provides |
pharmaceutical products
|
| gptkbp:range |
healthcare_products
|
| gptkbp:receives |
numerous awards
|
| gptkbp:research_areas |
gptkb:Beijing
|
| gptkbp:revenue |
over $30 billion
|
| gptkbp:services |
healthcare
|
| gptkbp:subsidiary |
gptkb:Sinopharm
|
| gptkbp:type |
state-owned enterprise
|